한글목차

세계 생세포 이미징 시장 규모는 2034년까지 연평균 11.7%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

시장 성장을 주도하는 현미경 기술의 발전

최근 공초점 현미경, 다광자 현미경, 초해상도 현미경과 같은 현미경 기술의 혁신은 생세포 이미징의 판도를 바꾸어 과학자들이 전례 없는 선명도와 정확도로 세포 과정의 역학을 깊이 파고들 수 있게 했습니다. 공초점 현미경은 핀홀을 사용하여 초점이 맞지 않는 빛을 선택적으로 제거하여 표본의 얇은 광학 절편을 보다 선명한 이미지로 만드는 것이 특징입니다. 이 기술은 기존 광시야 현미경에 비해 해상도와 콘트라스트를 향상시키고 광 손상을 최소화하여 생세포 이미징에 이상적입니다. 연구자들은 세포 분열, 이동, 미세 환경과의 상호 작용과 같은 과정을 연구하는 데 매우 중요한 복잡한 세포 구조와 역동적인 사건을 실시간으로 시각화할 수 있습니다.

장비 및 유지보수의 고비용성이 성장의 걸림돌로 작용할 가능성이 높음

공초점 현미경이나 초해상도 현미경과 같은 고급 이미징 시스템과 관련된 고비용은 특히 한정된 예산으로 운영되는 소규모 연구소나 연구기관에 큰 도전이 되고 있습니다. 첫째, 이러한 첨단 이미징 시스템을 구입하는 데 필요한 초기 설비 투자는 상당한 금액이 소요됩니다. 예를 들어, 공초점 현미경은 필요한 사양과 기능에 따라 수십만 달러에서 수백만 달러의 비용이 소요됩니다. 이러한 지출은 소규모 실험실의 경우 예산을 초과하는 경우가 많으며, 첨단 연구에 필수적인 이미징 툴을 확보하는 데 어려움을 겪습니다. 유지보수 비용은 더욱 큰 경제적 부담으로 작용합니다. 첨단 이미징 시스템은 최적의 성능을 보장하기 위해 정기적인 유지보수, 보정 및 가끔씩 수리가 필요합니다.

세계 생세포 이미징(Live Cell Imaging) 시장을 조사했으며, 시장 개요, 시장 성장에 영향을 미치는 요인과 시장 기회 분석, 시장 규모 추이 및 예측, 각 부문별/지역별/주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 보고서 개요

제2장 주요 요약

제3장 시장 개요

• 주요 조사 결과
• 시장 역학
• 영향 분석
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
• 공급망 분석
• 규제 프레임워크
• 신흥 시장과 메가트렌드
• Porter의 Five Forces 분석
• PEST 분석

제4장 생세포 이미징 시장 분석 : 기술별

• 주요 조사 결과
• 시장의 매력 지수
• 시장 규모 추이와 예측
• 기기
• 소모품
• 소프트웨어
• 서비스
  • 시장 규모 추이와 예측 : 지역별
  • 시장 점유율 : 지역별

제5장 생세포 이미징 시장 분석 : 기술별

• 주요 조사 결과
• 시장의 매력 지수
• 시장 규모 추이와 예측
• Fluorescence Recovery After Photobleaching (FRAP)
• Fluorescence Resonance Energy Transfer (FRET)
• High Content Screening (HCS)
• Live Cell Fluorescence Microscopy
• 기타
  • 시장 규모 추이와 예측 : 지역별
  • 시장 점유율 : 지역별

제6장 생세포 이미징 시장 분석 : 용도별

• 주요 조사 결과
• 시장의 매력 지수
• 시장 규모 추이와 예측
• 세포생물학
• 줄기세포
• Drug Discovery
• 기타
  • 시장 규모 추이와 예측 : 지역별
  • 시장 점유율 : 지역별

제7장 생세포 이미징 시장 분석 : 최종사용자별

• 주요 조사 결과
• 시장의 매력 지수
• 시장 규모 추이와 예측
• 제약 기업 및 바이오테크놀러지 기업
• 학술기관 및 연구기관
• 수탁 연구기관(CRO)
• 병원 및 진단실험실
• 기타
  • 시장 규모 추이와 예측 : 지역별
  • 시장 점유율 : 지역별

제8장 생세포 이미징 시장 분석 : 지역별

• 주요 조사 결과
• 시장 규모 추이와 예측

제9장 북미의 생세포 이미징 시장 분석

제10장 유럽의 생세포 이미징 시장 분석

제11장 아시아태평양의 생세포 이미징 시장 분석

제12장 라틴아메리카의 생세포 이미징 시장 분석

제13장 중동 및 아프리카의 생세포 이미징 시장 분석

제14장 기업 개요

• 경쟁 구도
• 전략적 전망
• Bio-Rad Laboratories
• BioTek Instruments, Inc.
• Bruker Corporation
• Carl Zeiss AG
• GE Healthcare Life Sciences
• Hamamatsu Photonics K.K.
• Leica Microsystems GmbH
• Molecular Devices, LLC
• NanoEnTek Inc.
• Nikon Instruments Inc.
• Olympus Corporation
• Oxford Instruments PLC
• PerkinElmer Inc.
• Thermo Fisher Scientific Inc.
• Merck KGaA

제15장 결론 및 제안

• Visiongain의 결론
• 시장 진출기업에 대한 제안

영문목차

The global Live Cell Imaging Market is projected to grow at a CAGR of 11.7% by 2034

The Live Cell Imaging Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Advancements in Microscopy Technologies Driving Market Growth

In recent years, innovations in microscopy techniques like confocal microscopy, multiphoton microscopy, and super-resolution microscopy have transformed the landscape of live cell imaging, enabling scientists to delve deeper into the dynamics of cellular processes with unprecedented clarity and precision. Confocal microscopy stands out by using a pinhole to selectively eliminate out-of-focus light, producing sharper images of thin optical sections within a specimen. This technique enhances resolution and contrast compared to traditional widefield microscopy, making it ideal for imaging live cells with minimal photodamage. Researchers can visualize intricate cellular structures and dynamic events in real-time, crucial for studying processes such as cell division, migration, and interaction with their microenvironment.

High Cost of Equipment and Maintenance Likely to Hamper Industry Growth

The high costs associated with advanced imaging systems like confocal microscopes and super-resolution microscopy setups present significant challenges, particularly for smaller research laboratories and institutions operating within limited budgets. Firstly, the initial capital investment required to purchase these advanced imaging systems can be substantial. Confocal microscopes, for example, can cost hundreds of thousands to millions of dollars depending on the specifications and capabilities needed. This expense often exceeds the available budget of smaller labs, hindering their ability to acquire essential imaging tools for cutting-edge research. Maintenance costs further compound the financial burden. Advanced imaging systems require regular maintenance, calibration, and occasional repairs to ensure optimal performance.

What Questions Should You Ask before Buying a Market Research Report?

• How is the live cell imaging market evolving?
• What is driving and restraining the live cell imaging market?
• How will each live cell imaging submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
• How will the market shares for each live cell imaging submarket develop from 2024 to 2034?
• What will be the main driver for the overall market from 2024 to 2034?
• Will leading live cell imaging markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
• Who are the leading players and what are their prospects over the forecast period?
• What are the live cell imaging projects for these leading companies?
• How will the industry evolve during the period between 2024 and 2034? What are the implications of live cell imaging projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the live cell imaging market?
• Where is the live cell imaging market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the live cell imaging market today, and over the next 10 years:

• Our 307-page report provides 109 tables and 186 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them - NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
• Forecasts to 2034 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising live cell imaging prices and recent developments.

Segments Covered in the Report

• Product Type
• Instruments
• Consumables
• Software
• Services
• Technology
• Fluorescence Recovery After Photobleaching (FRAP)
• Fluorescence Resonance Energy Transfer (FRET)
• High Content Screening (HCS)
• Live Cell Fluorescence Microscopy
• Others
• Application
• Cell Biology
• Stem Cell
• Drug Discovery
• Others
• End-User
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Hospitals & Diagnostic Laboratories
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America
• MEA
• GCC
• South Africa
• Rest of MEA

The report also includes profiles for some of the leading companies in the Live Cell Imaging Market, 2024 to 2034, with a focus on this segment of these companies' operations.

• Leading companies profiled in the report
• Bio-Rad Laboratories
• BioTek Instruments, Inc.
• Bruker Corporation
• Carl Zeiss AG
• GE Healthcare Life Sciences
• Hamamatsu Photonics K.K.
• Leica Microsystems GmbH
• Molecular Devices, LLC
• NanoEnTek Inc.
• Nikon Instruments Inc.
• Olympus Corporation
• Oxford Instruments PLC
• PerkinElmer Inc.
• Thermo Fisher Scientific Inc.
• Merck KGaA

Overall world revenue for Live Cell Imaging Market, 2024 to 2034 in terms of value the market will surpass US$3,177.0 million in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

• How will the Live Cell Imaging Market, 2024 to 2034 report help you?
• In summary, our 307+ page report provides you with the following knowledge:
• Revenue forecasts to 2034 for Live Cell Imaging Market, 2024 to 2034 Market, with forecasts for product type, technology, application, end-user, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2034 for five regional and 20 key national markets - See forecasts for the Live Cell Imaging Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the Live Cell Imaging Market, 2024 to 2034.
• Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
• Information found nowhere else
• With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Live Cell Imaging Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

• 1.1 Objectives of the Study
• 1.2 Introduction to Live Cell Imaging Market
• 1.3 What This Report Delivers
• 1.4 Why You Should Read This Report
• 1.5 Key Questions Answered by This Analytical Report
• 1.6 Who is This Report for?
• 1.7 Methodology
  • 1.7.1 Market Definitions
  • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.7.3 Data Validation
    • 1.7.3.1 Primary Research
    • 1.7.3.2 Secondary Research
• 1.8 Frequently Asked Questions (FAQs)
• 1.9 Associated Visiongain Reports
• 1.10 About Visiongain

2 Executive Summary

3 Market Overview

• 3.1 Key Findings
• 3.2 Market Dynamics
• 3.3 Impact Analysis
  • 3.3.1 Market Driving Factors
    • 3.3.1.1 Growing Investment from Academic Institutions and Biotechnology Companies
    • 3.3.1.2 Advancements in Microscopy Technologies
    • 3.3.1.3 Rising Demand in Drug Discovery and Development
    • 3.3.1.4 Growing Applications in Biomedical Research
  • 3.3.2 Market Restraining Factors
    • 3.3.2.1 High Cost of Equipment and Maintenance
    • 3.3.2.2 Complexity of Data Analysis
    • 3.3.2.3 Phototoxicity and Cell Viability
  • 3.3.3 Market Opportunities
    • 3.3.3.1 Integration with Artificial Intelligence and Machine Learning
    • 3.3.3.2 Growing Demand for Affordable Imaging Systems
    • 3.3.3.3 Expansion in Drug Discovery and Personalized Medicine
• 3.4 Supply Chain Analysis
• 3.5 Regulatory Framework
• 3.6 Emerging Markets and Megatrends
• 3.7 Porter's Five Forces Analysis
  • 3.7.1 Bargaining Power of Suppliers
  • 3.7.2 Bargaining Power of Buyers
  • 3.7.3 Competitive Rivalry
  • 3.7.4 Threat of Substitutes
  • 3.7.5 Threat of New Entrants
• 3.8 PEST Analysis

4 Live Cell Imaging Market Analysis by Product Type

• 4.1 Key Findings
• 4.2 Product Type Segment: Market Attractiveness Index
• 4.3 Live Cell Imaging Market Size Estimation and Forecast by Product Type
• 4.4 Instruments
  • 4.4.1 Market Size by Region, 2024-2034 (US$ Million)
  • 4.4.2 Market Share by Region, 2024 & 2034 (%)
• 4.5 Consumables
  • 4.5.1 Market Size by Region, 2024-2034 (US$ Million)
  • 4.5.2 Market Share by Region, 2024 & 2034 (%)
• 4.6 Software
  • 4.6.1 Market Size by Region, 2024-2034 (US$ Million)
  • 4.6.2 Market Share by Region, 2024 & 2034 (%)
• 4.7 Services
  • 4.7.1 Market Size by Region, 2024-2034 (US$ Million)
  • 4.7.2 Market Share by Region, 2024 & 2034 (%)

5 Live Cell Imaging Market Analysis by Technology

• 5.1 Key Findings
• 5.2 Technology Segment: Market Attractiveness Index
• 5.3 Live Cell Imaging Market Size Estimation and Forecast by Technology
• 5.4 Fluorescence Recovery After Photobleaching (FRAP)
  • 5.4.1 Market Size by Region, 2024-2034 (US$ Million)
  • 5.4.2 Market Share by Region, 2024 & 2034 (%)
• 5.5 Fluorescence Resonance Energy Transfer (FRET)
  • 5.5.1 Market Size by Region, 2024-2034 (US$ Million)
  • 5.5.2 Market Share by Region, 2024 & 2034 (%)
• 5.6 High Content Screening (HCS)
  • 5.6.1 Market Size by Region, 2024-2034 (US$ Million)
  • 5.6.2 Market Share by Region, 2024 & 2034 (%)
• 5.7 Live Cell Fluorescence Microscopy
  • 5.7.1 Market Size by Region, 2024-2034 (US$ Million)
  • 5.7.2 Market Share by Region, 2024 & 2034 (%)
• 5.8 Others
  • 5.8.1 Market Size by Region, 2024-2034 (US$ Million)
  • 5.8.2 Market Share by Region, 2024 & 2034 (%)

6 Live Cell Imaging Market Analysis by Application

• 6.1 Key Findings
• 6.2 Application Segment: Market Attractiveness Index
• 6.3 Live Cell Imaging Market Size Estimation and Forecast by Application
• 6.4 Cell Biology
  • 6.4.1 Market Size by Region, 2024-2034 (US$ Million)
  • 6.4.2 Market Share by Region, 2024 & 2034 (%)
• 6.5 Stem Cell
  • 6.5.1 Market Size by Region, 2024-2034 (US$ Million)
  • 6.5.2 Market Share by Region, 2024 & 2034 (%)
• 6.6 Drug Discovery
  • 6.6.1 Market Size by Region, 2024-2034 (US$ Million)
  • 6.6.2 Market Share by Region, 2024 & 2034 (%)
• 6.7 Others
  • 6.7.1 Market Size by Region, 2024-2034 (US$ Million)
  • 6.7.2 Market Share by Region, 2024 & 2034 (%)

7 Live Cell Imaging Market Analysis by End-User

• 7.1 Key Findings
• 7.2 End-User Segment: Market Attractiveness Index
• 7.3 Live Cell Imaging Market Size Estimation and Forecast by End-User
• 7.4 Pharmaceutical & Biotechnology Companies
  • 7.4.1 Market Size by Region, 2024-2034 (US$ Million)
  • 7.4.2 Market Share by Region, 2024 & 2034 (%)
• 7.5 Academic & Research Institutes
  • 7.5.1 Market Size by Region, 2024-2034 (US$ Million)
  • 7.5.2 Market Share by Region, 2024 & 2034 (%)
• 7.6 Contract Research Organizations (CROs)
  • 7.6.1 Market Size by Region, 2024-2034 (US$ Million)
  • 7.6.2 Market Share by Region, 2024 & 2034 (%)
• 7.7 Hospitals & Diagnostic Laboratories
  • 7.7.1 Market Size by Region, 2024-2034 (US$ Million)
  • 7.7.2 Market Share by Region, 2024 & 2034 (%)
• 7.8 Others
  • 7.8.1 Market Size by Region, 2024-2034 (US$ Million)
  • 7.8.2 Market Share by Region, 2024 & 2034 (%)

8 Live Cell Imaging Market Analysis by Region

• 8.1 Key Findings
• 8.2 Regional Market Size Estimation and Forecast

9 North America Live Cell Imaging Market Analysis

• 9.1 Key Findings
• 9.2 North America Live Cell Imaging Market Attractiveness Index
• 9.3 North America Live Cell Imaging Market by Country, 2024, 2029 & 2034 (US$ Million)
• 9.4 North America Live Cell Imaging Market Size Estimation and Forecast by Country
• 9.5 North America Live Cell Imaging Market Size Estimation and Forecast by Product Type
• 9.6 North America Live Cell Imaging Market Size Estimation and Forecast by Technology
• 9.7 North America Live Cell Imaging Market Size Estimation and Forecast by Application
• 9.8 North America Live Cell Imaging Market Size Estimation and Forecast by End-User
• 9.9 U.S. Live Cell Imaging Market Analysis
• 9.10 Canada Live Cell Imaging Market Analysis

10 Europe Live Cell Imaging Market Analysis

• 10.1 Key Findings
• 10.2 Europe Live Cell Imaging Market Attractiveness Index
• 10.3 Europe Live Cell Imaging Market by Country, 2024, 2029 & 2034 (US$ Million)
• 10.4 Europe Live Cell Imaging Market Size Estimation and Forecast by Country
• 10.5 Europe Live Cell Imaging Market Size Estimation and Forecast by Product Type
• 10.6 Europe Live Cell Imaging Market Size Estimation and Forecast by Technology
• 10.7 Europe Live Cell Imaging Market Size Estimation and Forecast by Application
• 10.8 Europe Live Cell Imaging Market Size Estimation and Forecast by End-User
• 10.9 Germany Live Cell Imaging Market Analysis
• 10.10 France Live Cell Imaging Market Analysis
• 10.11 UK Live Cell Imaging Market Analysis
• 10.12 Italy Live Cell Imaging Market Analysis
• 10.13 Spain Live Cell Imaging Market Analysis
• 10.14 Russia Live Cell Imaging Market Analysis
• 10.15 Rest of Europe Live Cell Imaging Market Analysis

11 Asia Pacific Live Cell Imaging Market Analysis

• 11.1 Key Findings
• 11.2 Asia Pacific Live Cell Imaging Market Attractiveness Index
• 11.3 Asia Pacific Live Cell Imaging Market by Country, 2024, 2029 & 2034 (US$ Million)
• 11.4 Asia Pacific Live Cell Imaging Market Size Estimation and Forecast by Country
• 11.5 Asia Pacific Live Cell Imaging Market Size Estimation and Forecast by Product Type
• 11.6 Asia Pacific Live Cell Imaging Market Size Estimation and Forecast by Technology
• 11.7 Asia Pacific Live Cell Imaging Market Size Estimation and Forecast by Application
• 11.8 Asia Pacific Live Cell Imaging Market Size Estimation and Forecast by End-User
• 11.9 Japan Live Cell Imaging Market Analysis
• 11.10 China Live Cell Imaging Market Analysis
• 11.11 India Live Cell Imaging Market Analysis
• 11.12 Australia Live Cell Imaging Market Analysis
• 11.13 South Korea Live Cell Imaging Market Analysis
• 11.14 Singapore Live Cell Imaging Market Analysis
• 11.15 Rest of Asia Pacific Live Cell Imaging Market Analysis

12 Latin America Live Cell Imaging Market Analysis

• 12.1 Key Findings
• 12.2 Latin America Live Cell Imaging Market Attractiveness Index
• 12.3 Latin America Live Cell Imaging Market by Country, 2024, 2029 & 2034 (US$ Million)
• 12.4 Latin America Live Cell Imaging Market Size Estimation and Forecast by Country
• 12.5 Latin America Live Cell Imaging Market Size Estimation and Forecast by Product Type
• 12.6 Latin America Live Cell Imaging Market Size Estimation and Forecast by Technology
• 12.7 Latin America Live Cell Imaging Market Size Estimation and Forecast by Application
• 12.8 Latin America Live Cell Imaging Market Size Estimation and Forecast by End-User
• 12.9 Brazil Live Cell Imaging Market Analysis
• 12.10 Mexico Live Cell Imaging Market Analysis
• 12.11 Argentina Live Cell Imaging Market Analysis
• 12.12 Colombia Live Cell Imaging Market Analysis
• 12.13 Rest of Latin America Live Cell Imaging Market Analysis

13 MEA Live Cell Imaging Market Analysis

• 13.1 Key Findings
• 13.2 MEA Live Cell Imaging Market Attractiveness Index
• 13.3 MEA Live Cell Imaging Market by Country, 2024, 2029 & 2034 (US$ Million)
• 13.4 MEA Live Cell Imaging Market Size Estimation and Forecast by Country
• 13.5 MEA Live Cell Imaging Market Size Estimation and Forecast by Product Type
• 13.6 MEA Live Cell Imaging Market Size Estimation and Forecast by Technology
• 13.7 MEA Live Cell Imaging Market Size Estimation and Forecast by Application
• 13.8 MEA Live Cell Imaging Market Size Estimation and Forecast by End-User
• 13.9 GCC Live Cell Imaging Market Analysis
• 13.10 South Africa Live Cell Imaging Market Analysis
• 13.11 Rest of MEA Live Cell Imaging Market Analysis

14 Company Profiles

• 14.1 Competitive Landscape, 2023
• 14.2 Strategic Outlook
• 14.3 Bio-Rad Laboratories
  • 14.3.1 Company Snapshot
  • 14.3.2 Company Overview
  • 14.3.3 Financial Analysis
    • 14.3.3.1 Net Revenue, 2018-2023
    • 14.3.3.2 Gross Profit, 2018-2023
    • 14.3.3.3 R&D, 2017-2022
  • 14.3.4 Product Benchmarking
  • 14.3.5 SWOT Analysis
• 14.4 BioTek Instruments, Inc.
  • 14.4.1 Company Snapshot
  • 14.4.2 Company Overview
  • 14.4.3 Product Benchmarking
  • 14.4.4 SWOT Analysis
• 14.5 Bruker Corporation
  • 14.5.1 Company Snapshot
  • 14.5.2 Company Overview
  • 14.5.3 Financial Analysis
    • 14.5.3.1 Net Revenue, 2018-2023
    • 14.5.3.2 Gross Profit, 2018-2023
  • 14.5.4 Product Benchmarking
  • 14.5.5 Strategic Outlook
  • 14.5.6 SWOT Analysis
• 14.6 Carl Zeiss AG
  • 14.6.1 Company Snapshot
  • 14.6.2 Company Overview
  • 14.6.3 Financial Analysis
    • 14.6.3.1 Net Revenue, 2018-2023
  • 14.6.4 Product Benchmarking
  • 14.6.5 SWOT Analysis
• 14.7 GE Healthcare Life Sciences
  • 14.7.1 Company Snapshot
  • 14.7.2 Company Overview
  • 14.7.3 Financial Analysis
    • 14.7.3.1 Net Revenue, 2018-2023
    • 14.7.3.2 Gross Profit, 2018-2023
    • 14.7.3.3 R&D, 2018-2023
  • 14.7.4 Product Benchmarking
  • 14.7.5 Strategic Outlook
  • 14.7.6 SWOT Analysis
• 14.8 Hamamatsu Photonics K.K.
  • 14.8.1 Company Snapshot
  • 14.8.2 Company Overview
  • 14.8.3 Financial Analysis
    • 14.8.3.1 Net Revenue, 2020-2023
  • 14.8.4 Product Benchmarking
  • 14.8.5 Strategic Outlook
  • 14.8.6 SWOT Analysis
• 14.9 Leica Microsystems GmbH
  • 14.9.1 Company Snapshot
  • 14.9.2 Company Overview
  • 14.9.3 Product Benchmarking
  • 14.9.4 Strategic Outlook
  • 14.9.5 SWOT Analysis
• 14.10 Molecular Devices, LLC
  • 14.10.1 Company Snapshot
  • 14.10.2 Company Overview
  • 14.10.3 Product Benchmarking
  • 14.10.4 SWOT Analysis
• 14.11 NanoEnTek Inc.
  • 14.11.1 Company Snapshot
  • 14.11.2 Company Overview
  • 14.11.3 Product Benchmarking
  • 14.11.4 SWOT Analysis
• 14.12 Nikon Instruments Inc.
  • 14.12.1 Company Snapshot
  • 14.12.2 Company Overview
  • 14.12.3 Financial Analysis
    • 14.12.3.1 Net Revenue, 2018-2023
    • 14.12.3.2 Gross Profit, 2018-2023
  • 14.12.4 Product Benchmarking
  • 14.12.5 Strategic Outlook
  • 14.12.6 SWOT Analysis
• 14.13 Olympus Corporation
  • 14.13.1 Company Snapshot
  • 14.13.2 Company Overview
  • 14.13.3 Financial Analysis
    • 14.13.3.1 Net Revenue, 2018-2022
    • 14.13.3.2 Gross Profit, 2018-2022
  • 14.13.4 Product Benchmarking
  • 14.13.5 SWOT Analysis
• 14.14 Oxford Instruments PLC
  • 14.14.1 Company Snapshot
  • 14.14.2 Company Overview
  • 14.14.3 Financial Analysis
    • 14.14.3.1 Net Revenue, 2018-2022
  • 14.14.4 Product Benchmarking
  • 14.14.5 SWOT Analysis
• 14.15 PerkinElmer Inc.
  • 14.15.1 Company Snapshot
  • 14.15.2 Company Overview
  • 14.15.3 Financial Analysis
    • 14.15.3.1 Net Revenue, 2018-2023
    • 14.15.3.2 Gross Profit, 2018-2023
    • 14.15.3.3 R&D Expense, 2018-2023
  • 14.15.4 Product Benchmarking
  • 14.15.5 SWOT Analysis
• 14.16 Thermo Fisher Scientific Inc.
  • 14.16.1 Company Snapshot
  • 14.16.2 Company Overview
  • 14.16.3 Financial Analysis
    • 14.16.3.1 Net Revenue, 2018-2023
    • 14.16.3.2 Gross Profit, 2018-2023
    • 14.16.3.3 R&D, 2018-2023
  • 14.16.4 Product Benchmarking
  • 14.16.5 SWOT Analysis
• 14.17 Merck KGaA
  • 14.17.1 Company Snapshot
  • 14.17.2 Company Overview
  • 14.17.3 Financial Analysis
    • 14.17.3.1 Net Revenue, 2018-2023
    • 14.17.3.2 Gross Profit, 2018-2023
    • 14.17.3.3 R&D Expense, 2018-2023
  • 14.17.4 Product Benchmarking
  • 14.17.5 SWOT Analysis

15 Conclusion and Recommendations

• 15.1 Concluding Remarks from Visiongain
• 15.2 Recommendations for Market Players